The Scientist

» patent, evolution and disease/medicine

Most Recent

image: Another Gene-Editing IPO

Another Gene-Editing IPO

By | April 12, 2016

Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.

0 Comments

image: Cancer Tissue Repository Launched

Cancer Tissue Repository Launched

By | April 11, 2016

The Dana-Farber Cancer Institute will store tissue samples from patients with leukemia and lymphoma from which scientists can make patient-derived mouse models.

0 Comments

image: Lightning-Fast Spider Bites

Lightning-Fast Spider Bites

By | April 8, 2016

Trap-jaw spiders have the fastest, most powerful bite of any arachnid, scientists show. 

0 Comments

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

Structural studies reveal how SSRI drugs bind to the human serotonin transporter.

0 Comments

image: Accomplished Biophysicist Dies

Accomplished Biophysicist Dies

By | April 5, 2016

Harold Morowitz, who dedicated his career to investigating the origins of life, has passed away at age 88.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | April 1, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Contributors

Contributors

By | April 1, 2016

Meet some of the people featured in the April 2016 issue of The Scientist.

0 Comments

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Systems-biology approaches offer new strategies for finding hard-to-identify drug targets for cancer.

0 Comments

image: Shooting for the Moon

Shooting for the Moon

By | April 1, 2016

Defeating cancer is many times more difficult than planting a flag on our lunar satellite.

4 Comments

image: Minimal Genome Created

Minimal Genome Created

By | March 24, 2016

Scientists build a living cellular organism with a genome smaller than any known in nature.

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech